Yale University, Digestive Diseases, Transplantation and Immunology, New Haven, United States; Royal Surrey County Hospital, Gastroenterology and Hepatology, Guilford, United Kingdom; Department of Clinical and Experimental Medicine, University of Surrey, Guilford, United Kingdom.
Royal Surrey County Hospital, Gastroenterology and Hepatology, Guilford, United Kingdom; Department of Clinical and Experimental Medicine, University of Surrey, Guilford, United Kingdom; King's College Hospital, Institute of Liver Studies, London, United Kingdom.
J Acad Consult Liaison Psychiatry. 2021 Sep-Oct;62(5):528-537. doi: 10.1016/j.jaclp.2021.04.004. Epub 2021 May 25.
Wilson disease (WD) is a chronic disorder of copper metabolism which may affect patient's quality of life (QOL).
Our aim was to assess the relationship between mental QOL (M-QOL) and physical QOL (P-QOL) and severity of the liver, neurological disease and mental health in patients with WD.
At enrollment into our multisite international WD registry, adults (n = 62) were administered examinations assessing QOL (Short-Form 12-Item Health Survey), cognition, and mood. Patients also underwent hepatology and neurological assessments.
Patients had lower M-QOL than P-QOL scores, P = 0.0006. Patients with major depressive disorder (n = 22) had worse M-QOL scores, P = 0.0017 but not P-QOL. We found no association with impaired cognition (n = 37) and QOL. The P-QOL scores have a moderate negative association with neurological disease severity based on the Unified Wilson Disease Rating Scale score (total [r = -0.38, P < 0.003], part 2 [r = -0.50, P < 0.0001], and part 3 [r = -0.37, P = 0.004]). M-QOL was not associated with Unified Wilson Disease Rating Scale scores. Worse P-QOL, but not M-QOL, was found in higher cirrhosis severity indicated by Child-Pugh (r = -0.80, P = 0.002) and Model for End Stage Liver Disease scores (r = -0.64, P = 0.03).
M-QOL was associated with depression but not cognitive impairment, neurological disease, or liver disease severity, suggesting that mental health issues may affect overall QOL independent of the degree of liver or neurological disease. P-QOL was affected by the severity of neurological and liver disease but not mental health but also contributes to overall QOL in WD. An appreciation of the range of problems that affect QOL in adults with WD will help health care providers address issues that could improve overall well-being. The Short-Form 12-Item Health Survey may provide a useful instrument for QOL surveillance in WD.
威尔逊病(WD)是一种慢性铜代谢紊乱疾病,可能会影响患者的生活质量(QOL)。
我们旨在评估 WD 患者的精神健康相关生活质量(M-QOL)和躯体健康相关生活质量(P-QOL)与肝脏、神经疾病和心理健康严重程度之间的关系。
在我们的多中心国际 WD 注册中心,我们招募了 62 名成年患者,对其进行了 QOL(简短 12 项健康调查)、认知和情绪评估。患者还进行了肝脏和神经学评估。
患者的 M-QOL 评分低于 P-QOL 评分,P=0.0006。22 名患有重度抑郁症的患者 M-QOL 评分较差,P=0.0017,但 P-QOL 评分不受影响。我们发现认知障碍(n=37)与 QOL 之间没有关联。P-QOL 评分与基于统一威尔逊病评定量表评分的神经疾病严重程度呈中度负相关(总分 [r=-0.38,P<0.003],第 2 部分 [r=-0.50,P<0.0001],第 3 部分 [r=-0.37,P=0.004])。M-QOL 与统一威尔逊病评定量表评分无关。Child-Pugh 评分(r=-0.80,P=0.002)和终末期肝病模型评分(r=-0.64,P=0.03)提示肝硬化严重程度越高,P-QOL 评分越差,但 M-QOL 评分不受影响。
M-QOL 与抑郁有关,但与认知障碍、神经疾病或肝脏疾病严重程度无关,这表明心理健康问题可能会影响整体 QOL,而与肝脏或神经疾病的严重程度无关。P-QOL 受神经和肝脏疾病严重程度的影响,但不受心理健康的影响,但也会影响 WD 患者的整体 QOL。了解影响 WD 成年患者生活质量的各种问题,有助于医疗保健提供者解决可能改善整体健康状况的问题。简短 12 项健康调查可能为 WD 的 QOL 监测提供有用的工具。